BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35489733)

  • 1. Tumor-infiltrating ICOS
    Kajikawa H; Hirata M; Haruna M; Ueyama A; Hirose K; Kawashima A; Iwahori K; Matsunaga K; Toyosawa S; Uzawa N; Wada H
    Anticancer Res; 2022 May; 42(5):2383-2393. PubMed ID: 35489733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
    Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
    Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion.
    Noda Y; Ishida M; Ueno Y; Fujisawa T; Iwai H; Tsuta K
    BMC Cancer; 2022 Apr; 22(1):402. PubMed ID: 35418058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating lymphocytes in oral cavity squamous cell carcinoma and its association with clinicopathological parameters.
    Ahuja S; Khan AA; Zaheer S; Ranga S
    Pathol Res Pract; 2023 Nov; 251():154882. PubMed ID: 37898039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICOS
    Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
    Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Concordant Disruption of B7/CD28 Immune Regulators Predicts the Prognosis of Oral Carcinomas.
    Chang SR; Chou CH; Liu CJ; Lin YC; Tu HF; Chang KW; Lin SC
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma.
    Kujan O; Agag M; Smaga M; Vaishnaw Y; Idrees M; Shearston K; Farah CS
    Pathology; 2022 Jun; 54(4):409-416. PubMed ID: 34872754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Density and location of CD3
    Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J
    J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic markers in oropharyngeal squamous cell carcinoma: focus on CD70 and tumour infiltrating lymphocytes.
    De Meulenaere A; Vermassen T; Aspeslagh S; Zwaenepoel K; Deron P; Duprez F; Rottey S; Ferdinande L
    Pathology; 2017 Jun; 49(4):397-404. PubMed ID: 28427753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoexpression of Tumor Infiltrating Lymphocytes(TILS) CD4 + and CD8 + in Oral Squamous Cell Carcinoma (OSCC) in Correlations with Clinicopathological Characteristics and Prognosis.
    Wahbi HS; Manadili A
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4177-4183. PubMed ID: 36580000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-checkpoint molecules on regulatory T-cells as a potential therapeutic target in head and neck squamous cell cancers.
    Suzuki S; Ogawa T; Sano R; Takahara T; Inukai D; Akira S; Tsuchida H; Yoshikawa K; Ueda R; Tsuzuki T
    Cancer Sci; 2020 Jun; 111(6):1943-1957. PubMed ID: 32304268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The repertoire of tumor-infiltrating lymphocytes within the microenvironment of oral squamous cell carcinoma reveals immune dysfunction.
    Quan H; Shan Z; Liu Z; Liu S; Yang L; Fang X; Li K; Wang B; Deng Z; Hu Y; Yao Z; Huang J; Yu J; Xia K; Tang Z; Fang L
    Cancer Immunol Immunother; 2020 Mar; 69(3):465-476. PubMed ID: 31950224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic role of tumour-infiltrating lymphocytes in oral squamous cell carcinoma: A meta-analysis.
    Huang Z; Xie N; Liu H; Wan Y; Zhu Y; Zhang M; Tao Y; Zhou H; Liu X; Hou J; Wang C
    J Oral Pathol Med; 2019 Oct; 48(9):788-798. PubMed ID: 31323145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
    BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma.
    Pratap Singh R; Kumari N; Gupta S; Jaiswal R; Mehrotra D; Singh S; Mukherjee S; Kumar R
    Microbiol Spectr; 2023 Aug; 11(4):e0459622. PubMed ID: 37409975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD79A work as a potential target for the prognosis of patients with OSCC: analysis of immune cell infiltration in oral squamous cell carcinoma based on the CIBERSORTx deconvolution algorithm.
    Yao S; Huang Z; Wei C; Wang Y; Xiao H; Chen S; Huang Z
    BMC Oral Health; 2023 Jun; 23(1):411. PubMed ID: 37344840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Density of Intratumor CD45RO
    Zhou C; Li J; Wu Y; Diao P; Yang J; Cheng J
    J Oral Maxillofac Surg; 2019 Mar; 77(3):536-545. PubMed ID: 30395824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD38 Multi-Functionality in Oral Squamous Cell Carcinoma: Prognostic Implications, Immune Balance, and Immune Checkpoint.
    Ding Z; He Y; Fu Y; Zhu N; Zhao M; Song Y; Huang X; Chen S; Yang Y; Zhang C; Hu Q; Ni Y; Ding L
    Front Oncol; 2021; 11():687430. PubMed ID: 34211854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma.
    Reichert TE; Scheuer C; Day R; Wagner W; Whiteside TL
    Cancer; 2001 Jun; 91(11):2136-47. PubMed ID: 11391595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.